The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: Meta-analysis.
about
When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank.Impact of antiretroviral therapy on clinical outcomes in HIV + kidney transplant recipients: Review of 58 cases.Novel Antiretroviral Drugs in Patients with Renal Impairment: Clinical and Pharmacokinetic Considerations.Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline.Drug interactions in HIV-infected patients treated for hepatitis C.HIV Infection and Bone Abnormalities.A review of drug-drug interactions in older HIV-infected patients.HIV and the menopause: A review.Renal outcomes in patients initiated on tenofovir disoproxil fumarate-based antiretroviral therapy at a community health centre in Malawi.Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load.Role of tenofovir alafenamide in the jungle of antiretroviral prescription.Incidence and predictors of tenofovir disoproxil fumarate-induced renal impairment in HIV infected Nigerian patients.A pharmacist-led medication switch protocol in an academic HIV clinic: patient knowledge and satisfaction.Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era
P2860
Q33765196-15EBCB3A-63B8-4D53-A2AB-55F58EADCB37Q37643344-22BEBE0B-FDC9-43AD-83F5-8589E6724723Q39074109-B08A62B7-8E5A-44D4-A005-A26C4E0C6479Q40046869-00E55B37-56F6-4BE1-80BA-60AF8456DC14Q40143109-6ACE7DEF-FCFB-432C-80ED-B1729FA3C9F9Q41877618-9FE40D7B-AF99-4E6D-8313-AACFEDC88580Q41996857-9DE78435-6B02-4023-95CC-C9C6EC79ED72Q47292815-C7D9C951-E071-402C-A9C4-38D272C8C6D6Q47553173-084907B6-FAFF-445C-ACE7-A988BE6AE58FQ49925457-77A92CD7-9629-442E-948A-01386971CF41Q50080891-DD6EF42B-9402-494A-AC78-1FB46D73C5A4Q55303657-0BAB3D18-695E-4935-AD98-1C412C30BCFAQ55475404-2223193C-6125-44BC-8D24-83ACE8289CA9Q59126145-50BEA56C-D561-404A-8C94-F3C47C7B9FDE
P2860
The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: Meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The efficacy and safety of ten ...... HIV-1 therapy: Meta-analysis.
@en
The efficacy and safety of ten ...... HIV-1 therapy: Meta-analysis.
@nl
type
label
The efficacy and safety of ten ...... HIV-1 therapy: Meta-analysis.
@en
The efficacy and safety of ten ...... HIV-1 therapy: Meta-analysis.
@nl
prefLabel
The efficacy and safety of ten ...... HIV-1 therapy: Meta-analysis.
@en
The efficacy and safety of ten ...... HIV-1 therapy: Meta-analysis.
@nl
P2093
P2860
P31
P921
P1433
P1476
The efficacy and safety of ten ...... HIV-1 therapy: Meta-analysis.
@en
P2093
P2860
P356
10.1097/MD.0000000000005146
P407
P5008
P577
2016-10-01T00:00:00Z